N
NuVasive Inc
F:NK8
NuVasive Inc
F:NK8
Price:
36.8
EUR
Market Closed
Market Cap:
€1.9B
Balance Sheet
Balance Sheet Decomposition
NuVasive Inc
NuVasive Inc
Balance Sheet Decomposition is not available for
NuVasive Inc
NuVasive Inc
Balance Sheet
NuVasive Inc
NuVasive Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
103
|
142
|
192
|
154
|
73
|
118
|
213
|
857
|
246
|
249
|
|
| Cash Equivalents |
103
|
142
|
192
|
154
|
73
|
118
|
213
|
857
|
246
|
249
|
|
| Short-Term Investments |
143
|
220
|
165
|
0
|
0
|
0
|
0
|
173
|
0
|
0
|
|
| Total Receivables |
105
|
119
|
128
|
172
|
200
|
197
|
212
|
207
|
214
|
249
|
|
| Accounts Receivables |
105
|
119
|
128
|
172
|
200
|
197
|
212
|
207
|
214
|
249
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
137
|
155
|
168
|
208
|
247
|
273
|
312
|
301
|
316
|
339
|
|
| Other Current Assets |
48
|
22
|
49
|
42
|
40
|
31
|
27
|
25
|
26
|
29
|
|
| Total Current Assets |
536
|
658
|
703
|
575
|
560
|
618
|
764
|
1 562
|
802
|
865
|
|
| PP&E Net |
128
|
129
|
141
|
182
|
215
|
239
|
333
|
389
|
407
|
442
|
|
| PP&E Gross |
128
|
129
|
0
|
182
|
0
|
239
|
333
|
389
|
407
|
442
|
|
| Accumulated Depreciation |
149
|
174
|
0
|
223
|
0
|
338
|
393
|
453
|
503
|
573
|
|
| Intangible Assets |
94
|
97
|
85
|
291
|
281
|
252
|
201
|
152
|
243
|
184
|
|
| Goodwill |
155
|
154
|
154
|
486
|
537
|
561
|
561
|
560
|
633
|
640
|
|
| Long-Term Investments |
80
|
43
|
112
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
187
|
261
|
107
|
37
|
47
|
37
|
26
|
30
|
69
|
94
|
|
| Other Assets |
155
|
154
|
154
|
486
|
537
|
561
|
561
|
560
|
633
|
640
|
|
| Total Assets |
1 180
N/A
|
1 342
+14%
|
1 303
-3%
|
1 571
+21%
|
1 640
+4%
|
1 708
+4%
|
1 885
+10%
|
2 693
+43%
|
2 154
-20%
|
2 225
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
14
|
14
|
61
|
9
|
76
|
9
|
12
|
17
|
16
|
20
|
|
| Accrued Liabilities |
54
|
87
|
38
|
93
|
56
|
130
|
155
|
136
|
153
|
147
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
62
|
0
|
0
|
0
|
645
|
0
|
448
|
|
| Other Current Liabilities |
49
|
113
|
1
|
78
|
30
|
40
|
40
|
38
|
31
|
101
|
|
| Total Current Liabilities |
117
|
214
|
100
|
243
|
161
|
180
|
207
|
836
|
201
|
716
|
|
| Long-Term Debt |
346
|
361
|
373
|
564
|
583
|
603
|
624
|
773
|
886
|
445
|
|
| Deferred Income Tax |
3
|
11
|
9
|
19
|
19
|
5
|
15
|
3
|
3
|
13
|
|
| Minority Interest |
9
|
8
|
7
|
6
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
108
|
107
|
103
|
45
|
78
|
86
|
124
|
162
|
269
|
181
|
|
| Total Liabilities |
584
N/A
|
702
+20%
|
591
-16%
|
876
+48%
|
845
-4%
|
873
+3%
|
970
+11%
|
1 774
+83%
|
1 359
-23%
|
1 356
0%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
170
|
187
|
104
|
67
|
5
|
17
|
83
|
45
|
46
|
86
|
|
| Additional Paid In Capital |
769
|
847
|
989
|
1 010
|
1 364
|
1 398
|
1 430
|
1 550
|
1 435
|
1 469
|
|
| Treasury Stock |
0
|
11
|
162
|
238
|
566
|
572
|
588
|
669
|
678
|
683
|
|
| Other Equity |
3
|
10
|
12
|
11
|
7
|
9
|
9
|
8
|
8
|
3
|
|
| Total Equity |
596
N/A
|
640
+7%
|
712
+11%
|
695
-2%
|
796
+14%
|
835
+5%
|
915
+10%
|
919
+0%
|
795
-13%
|
869
+9%
|
|
| Total Liabilities & Equity |
1 180
N/A
|
1 342
+14%
|
1 303
-3%
|
1 571
+21%
|
1 640
+4%
|
1 708
+4%
|
1 885
+10%
|
2 693
+43%
|
2 154
-20%
|
2 225
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
45
|
48
|
49
|
50
|
51
|
52
|
52
|
51
|
52
|
52
|
|
Switch to:
Switch to:
See Also
Discover More
